Literature DB >> 11134947

Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1.

E O Saphire1, P W Parren, C F Barbas, D R Burton, I A Wilson.   

Abstract

An intact human immunoglobulin with a full-length hinge has been crystallized for the first time in a form in which all of the Ig domains are ordered. The IgG1 antibody b12 is one of only three known monoclonal antibodies described that potently neutralize a broad range of HIV-1 primary isolates. It binds to an epitope overlapping the conserved CD4 binding site on the viral surface antigen gp120. Hexagonal crystals corresponding to space group R32 were grown from 0.8 M ammonium sulfate, with unit-cell parameters a = b = 271.3, c = 175.2 A and one molecule per asymmetric unit. The crystals diffract to 2.8 A and a preliminary molecular-replacement solution indicates that all 12 Ig domains of the antibody can be resolved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134947     DOI: 10.1107/s0907444900017376

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  20 in total

1.  Phase behavior of an intact monoclonal antibody.

Authors:  Tangir Ahamed; Beatriz N A Esteban; Marcel Ottens; Gijs W K van Dedem; Luuk A M van der Wielen; Marc A T Bisschops; Albert Lee; Christine Pham; Jörg Thömmes
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

2.  The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen.

Authors:  Ivan Correia; Joyce Sung; Randall Burton; Clarissa G Jakob; Bridget Carragher; Tariq Ghayur; Czeslaw Radziejewski
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

3.  Explaining the non-newtonian character of aggregating monoclonal antibody solutions using small-angle neutron scattering.

Authors:  Maria Monica Castellanos; Jai A Pathak; William Leach; Steven M Bishop; Ralph H Colby
Journal:  Biophys J       Date:  2014-07-15       Impact factor: 4.033

4.  Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.

Authors:  Royce A Wilkinson; Chayne Piscitelli; Martin Teintze; Lisa A Cavacini; Marshall R Posner; C Martin Lawrence
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.

Authors:  Megan E Mefford; Kevin Kunstman; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

6.  Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability.

Authors:  Joshua D Ramsey; Michelle L Gill; Tim J Kamerzell; E Shane Price; Sangeeta B Joshi; Steven M Bishop; Cynthia N Oliver; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2009-07       Impact factor: 3.534

7.  Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG.

Authors:  Julia Gavrilyuk; Hitoshi Ban; Hisatoshi Uehara; Shannon J Sirk; Karen Saye-Francisco; Angelica Cuevas; Elise Zablowsky; Avinash Oza; Michael S Seaman; Dennis R Burton; Carlos F Barbas
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

8.  Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.

Authors:  Xueling Wu; Tongqing Zhou; Sijy O'Dell; Richard T Wyatt; Peter D Kwong; John R Mascola
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

9.  Crystalline monoclonal antibodies for subcutaneous delivery.

Authors:  Mark X Yang; Bhami Shenoy; Matthew Disttler; Reena Patel; Margaret McGrath; Sergey Pechenov; Alexey L Margolin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

10.  Global structures of IgG isotypes expressing identical variable regions.

Authors:  Ertan Eryilmaz; Alena Janda; Jungwook Kim; Radames J B Cordero; David Cowburn; Arturo Casadevall
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.